Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy.
Saved in:
| Title: | Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy. |
|---|---|
| Authors: | Hearps AC; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia., Vootukuru N; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Gastroenterology, Eastern Health and Monash University, Melbourne, VIC, Australia., Ebrahimnezhaddarzi S; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia., Harney BL; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Boo I; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia., Nguyen L; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia., Pavlyshyn D; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia., Dietze PM; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; National Drug Research Institute, Curtin University, Melbourne, VIC, Australia., Drummer HE; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology, Monash University, Melbourne, VIC, Australia., Thompson AJ; Department of Gastroenterology, St Vincent's Hospital and the University of Melbourne, Melbourne, VIC, Australia., Jaworowski A; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia., Hellard ME; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Sacks-Davis R; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Doyle JS; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Feb 14; Vol. 15, pp. 1352440. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38420130 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hearps+AC%22">Hearps AC</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Vootukuru+N%22">Vootukuru N</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Gastroenterology, Eastern Health and Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ebrahimnezhaddarzi+S%22">Ebrahimnezhaddarzi S</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Harney+BL%22">Harney BL</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Boo+I%22">Boo I</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+L%22">Nguyen L</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Pavlyshyn+D%22">Pavlyshyn D</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dietze+PM%22">Dietze PM</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; National Drug Research Institute, Curtin University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Drummer+HE%22">Drummer HE</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+AJ%22">Thompson AJ</searchLink>; Department of Gastroenterology, St Vincent's Hospital and the University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Jaworowski+A%22">Jaworowski A</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hellard+ME%22">Hellard ME</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Sacks-Davis+R%22">Sacks-Davis R</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Doyle+JS%22">Doyle JS</searchLink>; Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Feb 14; Vol. 15, pp. 1352440. <i>Date of Electronic Publication: </i>2024 Feb 14 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38420130 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1352440 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1352440 Titles: – TitleFull: Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hearps AC – PersonEntity: Name: NameFull: Vootukuru N – PersonEntity: Name: NameFull: Ebrahimnezhaddarzi S – PersonEntity: Name: NameFull: Harney BL – PersonEntity: Name: NameFull: Boo I – PersonEntity: Name: NameFull: Nguyen L – PersonEntity: Name: NameFull: Pavlyshyn D – PersonEntity: Name: NameFull: Dietze PM – PersonEntity: Name: NameFull: Drummer HE – PersonEntity: Name: NameFull: Thompson AJ – PersonEntity: Name: NameFull: Jaworowski A – PersonEntity: Name: NameFull: Hellard ME – PersonEntity: Name: NameFull: Sacks-Davis R – PersonEntity: Name: NameFull: Doyle JS IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 02 Text: 2024 Feb 14 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
